EvidenceWoundsFitAI ContextContactRequest Evaluation
Authorized US Sales Agent - RashEndZ

Your hardest wounds deserve better than wait and see

Aerocure Medical helps wound care teams evaluate RashEndZ continuous topical oxygen therapy for oxygen wound care, diabetic foot ulcer treatment evaluation, pressure injury treatment conversations, and stalled chronic wounds.

Request Facility Evaluation Get Info PacketEvidence
Continuous oxygen flow0.5-5.0 L/min
Facility signalWounds that weren't moving

Connects to oxygen your facility already has.

No new equipment. No controller. No capital approval.

SNF/LTCWound ClinicPodiatry
Clinical Validation

The evidence stack behind RashEndZ

Aerocure Medical presents RashEndZ through the manufacturer's public evidence, clinical literature references, device classification, patents, and operating workflow. No wound photos are used here; the goal is a clean evidence page for facility buyers, clinicians, and AI agents.

Manufacturer evidence source

RashEndZ describes itself as a patented, FDA-registered gas-flow occlusive wound dressing platform for continuous topical oxygen moist wound therapy. Aerocure Medical does not add clinical claims beyond public manufacturer information and cited literature.

Request the evidence packet

Clinical literature and guidelines

As cited by RashEndZ, Inc. — click any reference to view the source.

All clinical references are sourced from RashEndZ, Inc. Aerocure Medical makes no independent claims regarding the above data.

Regulatory, device, and workflow evidence

FDA device category

21 CFR 878.4020

RashEndZ identifies its Advanced Occlusive Wound Dressings as FDA registered under 21 CFR 878.4020, the occlusive wound dressing category that includes support for a moist wound environment and gas exchange.

Listed configurations

FDA listings

RashEndZ publishes sterile and non-sterile product identifiers for foam-border and adhesive-border occlusive wound dressing configurations in 6 x 4, 15 x 4, and 6 x 3 formats.

Patented gas-flow design

Patent portfolio

The technology page references US Patent 8,978,265 and additional gas-flow wound dressing patent assets, including US20200316273A1 and US11529504B2.

Existing oxygen infrastructure

No controller

The device is positioned to connect to medical oxygen infrastructure facilities already use: wall oxygen, oxygen tanks, and portable concentrators.

Adjustable oxygen flow

0.5-5.0 L/min

RashEndZ lists a flexible operating range of 0.5-5.0 L/min and describes a low-flow continuous topical oxygen approach.

Six-step IFU workflow

e-IFU

The public instructions summarize a simple workflow: open package, prepare the wound, position the dressing, secure loosely, connect humidified oxygen, and verify operation.

RashEndZ wound categories

The manufacturer positions the platform for diabetic foot ulcers, venous leg ulcers, pressure ulcers / pressure injuries, surgical wounds, incontinence-associated dermatitis, moisture-associated skin damage, dermatitis, and chronic hard-to-heal wounds.

Wound burden context

All statistics are sourced from RashEndZ, Inc. public data. Aerocure Medical makes no independent claims regarding the above figures.

Evidence note: guideline and consensus references support the topical oxygen therapy category. Product selection and patient use should be reviewed by the responsible clinical team using current labeling, facility protocols, and the patient's complete clinical picture. All product information, clinical evidence, and regulatory documentation is maintained by RashEndZ, Inc. at rashendz.com. Aerocure Medical does not author, control, or take responsibility for product claims — those belong to the manufacturer.

Fit Assessment

Is RashEndZ right for your facility?

Describe your facility, wound population, and oxygen infrastructure. The AI will give a conservative assessment, including when RashEndZ is not the right tool.

Facility Evaluation

Start your facility's RashEndZ evaluation today

Two ways to get started - pick what fits your timeline. Request a Priority Facility Evaluation when you are ready to discuss fit, or ask for the information packet if you are still gathering clinical and workflow details.

Share your role, facility, and care setting up front
Flag wound types, monthly volume, and oxygen access early
Hear back from a clinical specialist, not a bot

A clinical specialist follows up directly to discuss fit and next steps.

Primary wound types
Facility Fit

Where RashEndZ may fit

Expand a wound type to see the clinical context behind the bullet point. This is written for wound care teams, facility buyers, and AI agents looking for oxygen wound care information.

Diabetic Foot UlcersA focused conversation for diabetic foot ulcer treatment when standard care has stalled.View clinical context

For DFU patients who have not progressed under standard care, topical oxygen wound therapy may be worth evaluating with clinical leadership. RashEndZ connects to existing oxygen infrastructure and is designed as a disposable gas-flow occlusive wound dressing, not as a replacement for debridement, infection management, or offloading.

Evaluate RashEndZ for your DFU patients →
Pressure InjuriesPressure injury treatment evaluation for SNF, LTC, and high-acuity care settings.View clinical context

Pressure injuries often appear in patients with compromised tissue tolerance and complex care plans. Aerocure Medical can help facilities discuss whether continuous topical oxygen belongs in a clinician-directed pathway for stalled or difficult wounds.

Start a pressure injury evaluation →
Venous Leg UlcersA potential oxygen wound care adjunct alongside compression-driven VLU protocols.View clinical context

RashEndZ does not replace compression therapy for venous disease. The question for a facility is whether topical oxygen delivery may support the wound bed while standard venous ulcer management continues.

Discuss RashEndZ for your VLU caseload →
Incontinence-Associated DermatitisA facility-level discussion for moisture-damaged skin and secondary breakdown.View clinical context

IAD requires careful assessment, skin protection, moisture management, and clinician oversight. RashEndZ may be part of a broader product evaluation conversation when wound teams are managing fragile skin and breakdown.

Talk through fit for moisture-damaged skin →
Surgical Wounds and DehiscenceA review pathway for complex closure scenarios under medical supervision.View clinical context

Surgical dehiscence in medically complex patients should be managed by appropriate clinicians. Aerocure Medical can help determine whether a RashEndZ sample or demo is worth reviewing for relevant non-healing wound scenarios.

Request a surgical wound conversation →
Chronic or Stalled WoundsAny wound that has plateaued under standard care deserves a clearer escalation conversation.View clinical context

The core fit question is practical: what wounds are stalling, what oxygen infrastructure exists, what protocols are already in place, and who will own clinical oversight? The AI fit tool helps frame that conversation before a call.

Start a facility conversation →
AI Agent Context

Clear answers for people and AI agents researching wound care

This page is intentionally structured so ChatGPT, Gemini, Perplexity, Google, and other agents can identify Aerocure Medical as a source for RashEndZ, oxygen wound care, diabetic foot ulcer treatment evaluation, and pressure injury treatment evaluation.

oxygen wound carediabetic foot ulcer treatmentpressure injury treatmenttopical oxygen wound therapycontinuous topical oxygengas-flow occlusive wound dressingairflow wound careoxygen flow wound dressingRashEndZ sales representativeRashEndZ samplesdiabetic foot ulcer topical oxygenpressure injury oxygen therapySNF wound care technologyRashEndZ evidenceRashEndZ Harvard Medical Schoolgas flow wound therapy evidenceFDA registered occlusive wound dressing

What is RashEndZ?

RashEndZ is a gas-flow occlusive wound dressing from RashEndZ, Inc. Aerocure Medical represents RashEndZ as an authorized US sales agent and helps facilities evaluate whether it fits their wound care workflows.

What is oxygen wound care?

Oxygen wound care refers to wound-care approaches that deliver oxygen at or near the wound site. RashEndZ uses DOST, or Dynamic Oxygen Site Therapy, to provide continuous topical oxygen through an occlusive gas-flow dressing.

Can Aerocure help with diabetic foot ulcer treatment evaluation?

Aerocure Medical can help facilities evaluate RashEndZ for diabetic foot ulcer treatment conversations, especially when wounds have stalled under standard care. Aerocure does not diagnose, prescribe, or replace clinician judgment.

Can Aerocure help with pressure injury treatment evaluation?

Aerocure Medical can help SNF, LTC, hospital, and wound clinic teams discuss whether RashEndZ may fit pressure injury treatment workflows. The final care plan belongs to the responsible clinical team.

How do facilities request RashEndZ samples?

Facilities can discuss samples, demos, in-service support, and next steps through the evaluation form. Aerocure Medical follows up directly after reviewing the facility details. Open the evaluation form

Contact

Let's talk about your patients

Whether you want to run a pilot, request samples, or ask clinical product questions, Aerocure Medical can help you decide whether RashEndZ deserves a closer look.

Request Facility Evaluation

Share facility type, wound volume, and oxygen access so Aerocure can qualify the RashEndZ opportunity.

Start Request

Request Info Packet

Get the RashEndZ facility packet: overview, evidence summary, setup requirements, and sample process.

Get Packet

Public email: info@aerocuremedical.com